FDA Investigator Qing Joanna Zhou, PhD

Qing Joanna Zhou, PhD has conducted inspections on 3 sites in 2 countries as of 11 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
3
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100003367
Countries of Inspections:
United States of America, Germany
FDA Investigators that have inspected at least one site in common with Qing Joanna Zhou, PhD:
Amir Alavi, Anh M Lac, Anita Narula, PhD, Ann L Demarco, Ashar P Parikh, Azza Talaat, Bo Chi, PhD, Brenda W Uratani, PhD, Burnell M Henry, Carl Lee, Carolyn A Renshaw, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Christopher Downey, PhD, Concepcion Cruz, Jr, Cynthia Jim, CSO, Daryl A Dewoskin, David G Eng, Deborah J Parris, Diane L Raccasi, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Eliezar Ramos, Erika V Butler, Felix Maldonado, Helen B Ricalde, Henry K Lau, Jacqueline Mdiaz Albertini, James R Evans, Jeffrey M Watson, John D White, John P Mistler, Joseph Kutze, PhD, Julie D Bringger, Junho Pak, Kalavati Suvarna, PhD, Kathleen R Jones, PhD, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kevin A Gonzalez, Kouros Kangarli, Kristina J Donohue, Kurt A Brorson, PhD, Lance Mde Souza, MBA, Larry K Austin, Laurie Graham, LCDR Debra Emerson, Linan Ha, PhD, Lucila B Nwatu, Mariza M Jafary, Mark Brunswick, PhD, Marshalette O Edwards, Mary E Storch, Megan A Haggerty, Michael Shanks, MS, Michele L Forster, PhD, Michelle Rfrazier Jessen, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Milos Dokmanovic, PhD, Monica Commerford, PhD, Mra Munizn, Nancy T Waites, Natalia Pripuzova, PhD, Nicholas L Hunt, Nicole K Trudel, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Paula A Trost, Peter E Baker, Prabhu P Raju, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Richard W Berning, Robert D Tollefsen, Robert Jennings, Rose Ashley, Ruth Moore, PhD, Scott N Lim, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Stacey S Degarmo, Stephanie A Slater, MS, Thomas J Arista, Thuy T Nguyen, LCDR, Uttaniti Limchumroon (Tom), Veronica Fuentes, MS, Virgilio F Pacio, CSO, Walter N Lange, Wayne E Seifert, William V Millar, Yanming An, PhD, Zerita White, Zhong Li, PhD, Ziyang Su, PhD

Qing Joanna Zhou, PhD's Documents

Publish Date Document Type Title
November, 2015 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2015-11-13
November, 2015 EIR Boehringer Ingelheim Pharma GmbH and Co. KG - EIR, 2015-11-24
September, 2013 FDA 483 AbbVie Bioresearch Center - Form 483, 2013-09-13
March, 2012 FDA 483 Genentech, Inc. - Form 483, 2012-03-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more